Third Harmonic Bio Inc (THRD) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:THRD • US88427A1079

5.38 USD
0 (-0.09%)
At close: Jul 30, 2025
5.38 USD
0 (0%)
After Hours: 7/30/2025, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Overall THRD gets a fundamental rating of 3 out of 10. We evaluated THRD against 191 industry peers in the Pharmaceuticals industry. While THRD has a great health rating, there are worries on its profitability. THRD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year THRD has reported negative net income.
  • In the past year THRD has reported a negative cash flow from operations.
  • THRD had negative earnings in each of the past 5 years.
  • In the past 5 years THRD always reported negative operating cash flow.
THRD Yearly Net Income VS EBIT VS OCF VS FCFTHRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

  • THRD has a better Return On Assets (-19.10%) than 61.34% of its industry peers.
  • THRD has a Return On Equity of -19.60%. This is in the better half of the industry: THRD outperforms 70.62% of its industry peers.
Industry RankSector Rank
ROA -19.1%
ROE -19.6%
ROIC N/A
ROA(3y)-12.77%
ROA(5y)-42.74%
ROE(3y)-13.19%
ROE(5y)-866.71%
ROIC(3y)N/A
ROIC(5y)N/A
THRD Yearly ROA, ROE, ROICTHRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -1K -2K -3K -4K

1.3 Margins

  • THRD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
THRD Yearly Profit, Operating, Gross MarginsTHRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • The number of shares outstanding for THRD has been increased compared to 1 year ago.
  • THRD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
THRD Yearly Shares OutstandingTHRD Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M
THRD Yearly Total Debt VS Total AssetsTHRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • An Altman-Z score of 19.69 indicates that THRD is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 19.69, THRD belongs to the best of the industry, outperforming 93.30% of the companies in the same industry.
  • There is no outstanding debt for THRD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 19.69
ROIC/WACCN/A
WACCN/A
THRD Yearly LT Debt VS Equity VS FCFTHRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

  • THRD has a Current Ratio of 54.10. This indicates that THRD is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 54.10, THRD belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • A Quick Ratio of 54.10 indicates that THRD has no problem at all paying its short term obligations.
  • THRD has a Quick ratio of 54.10. This is amongst the best in the industry. THRD outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 54.1
Quick Ratio 54.1
THRD Yearly Current Assets VS Current LiabilitesTHRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • THRD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -89.33%.
EPS 1Y (TTM)-89.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • THRD is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.93% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y26.11%
EPS Next 2Y11.22%
EPS Next 3Y7.35%
EPS Next 5Y1.93%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
THRD Yearly Revenue VS EstimatesTHRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2031 2032 2M 4M 6M 8M 10M
THRD Yearly EPS VS EstimatesTHRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 -2

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • THRD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year THRD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
THRD Price Earnings VS Forward Price EarningsTHRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
THRD Per share dataTHRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.22%
EPS Next 3Y7.35%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • THRD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

Third Harmonic Bio Inc

NASDAQ:THRD (7/30/2025, 8:00:01 PM)

After market: 5.38 0 (0%)

5.38

0 (-0.09%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)08-06
Earnings (Next)11-05
Inst Owners67.3%
Inst Owner Change-84.68%
Ins Owners0.48%
Ins Owner Change-66.04%
Market Cap242.80M
Revenue(TTM)N/A
Net Income(TTM)-53.45M
Analysts43.33
Price Target3.06 (-43.12%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-27.69%
Min EPS beat(2)-38.41%
Max EPS beat(2)-16.98%
EPS beat(4)1
Avg EPS beat(4)-14.5%
Min EPS beat(4)-38.41%
Max EPS beat(4)5.59%
EPS beat(8)5
Avg EPS beat(8)11.71%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-29.41%
PT rev (3m)-34.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.07%
EPS NY rev (1m)0%
EPS NY rev (3m)7.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.89
P/tB 0.89
EV/EBITDA N/A
EPS(TTM)-1.42
EYN/A
EPS(NY)-0.97
Fwd EYN/A
FCF(TTM)-0.92
FCFYN/A
OCF(TTM)-0.92
OCFYN/A
SpS0
BVpS6.04
TBVpS6.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -19.1%
ROE -19.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-12.77%
ROA(5y)-42.74%
ROE(3y)-13.19%
ROE(5y)-866.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 54.1
Quick Ratio 54.1
Altman-Z 19.69
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-89.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75%
EPS Next Y26.11%
EPS Next 2Y11.22%
EPS Next 3Y7.35%
EPS Next 5Y1.93%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-53.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.31%
EBIT Next 3Y-16.07%
EBIT Next 5Y-2.76%
FCF growth 1Y-24.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-24.48%
OCF growth 3YN/A
OCF growth 5YN/A

Third Harmonic Bio Inc / THRD FAQ

What is the fundamental rating for THRD stock?

ChartMill assigns a fundamental rating of 3 / 10 to THRD.


What is the valuation status for THRD stock?

ChartMill assigns a valuation rating of 0 / 10 to Third Harmonic Bio Inc (THRD). This can be considered as Overvalued.


Can you provide the profitability details for Third Harmonic Bio Inc?

Third Harmonic Bio Inc (THRD) has a profitability rating of 1 / 10.


What is the financial health of Third Harmonic Bio Inc (THRD) stock?

The financial health rating of Third Harmonic Bio Inc (THRD) is 8 / 10.